Chrome Extension
WeChat Mini Program
Use on ChatGLM

A Common Tumour in a Rare Location: a Single Centre Case Series of Cerebellar Glioblastoma.

BRITISH JOURNAL OF NEUROSURGERY(2024)

Queens Med Ctr

Cited 0|Views19
Abstract
Although glioblastoma is the commonest primary brain tumour in adults, its location in the cerebellum is extremely rare. We present thirteen cases (3 female, 10 male; median age at presentation 56 [age range 21-77]) of surgically managed, histologically confirmed, primary cerebellar glioblastoma (cGB) over a 17 year period (2005-2022). Pre-operative radiological diagnosis was challenging given cGB rarity, although MRI demonstrated ring enhancement in all cases. Surgical management included posterior fossa craniectomy and debulking in 11 cases and burr hole biopsy in two. CSF diversion was necessary in four cases. No evidence of IDH or ATRX gene mutations was found when tested. Survival ranged from 1 to 22 months after diagnosis (mean 10.9 months). We also seek to understand why glioblastoma is rare in this location and discuss potential reasons for this. We hypothesise that increasing anatomical distance from germinal regions and decreased local endogenous neural stem cell activity (which has been associated with glioblastoma) may explain why glioblastoma is rare in the cerebellum. We hereby seek to add to the limited literature on cGB as this is the largest UK cGB series to date.
More
Translated text
Key words
Cerebellar glioblastoma,glioma,high grade glioma,neural stem cell,posterior fossa,glioblastoma
求助PDF
上传PDF
Bibtex
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
  • Pretraining has recently greatly promoted the development of natural language processing (NLP)
  • We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
  • We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
  • The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
  • Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Upload PDF to Generate Summary
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Related Papers
INSERM U10 Cancer Research Center of Lyon,Hospices Civils de Lyon, IMA-Brain, INSERM U8 Institut de Psychiatrie et Neurosciences de Paris, Inserm U10 INRA U13 INSA Lyon, Université Claude Bernard Lyon, Institut de Neurophysiopathologie, UMR , Université D’Aix-Marseille,Zouaoui Sonia, Inserm U12 UMR , Université de Lyon,Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, INSERM U10 Hôpital Saint Eloi,Guyotat Jacques
2021

被引用7 | 浏览

Cancer Research Center of Lyon, Université Claude Bernard Lyon, Department of Neuropathology, Institut de Psychiatrie et Neurosciences de Paris, Université d’Aix-Marseille, ICM, Department of Neurooncology,Pelissou-Guyotat Isabelle, Université de Lyon, Hôpital Saint Eloi,Guyotat Jacques
2021

被引用6 | 浏览

Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper

要点】:本文报道了13例经手术管理和病理确认的原发性小脑胶质oblastoma病例,探讨了该病在小脑部位罕见的原因,并提出了解释其罕见性的新假说。

方法】:通过回顾性分析2005至2022年间13例原发性小脑胶质oblastoma患者的临床资料,结合影像学特征和基因突变检测结果进行研究。

实验】:对13例病例进行手术管理,包括后颅窝减压和肿瘤减容术11例,钻孔活检术2例;4例行脑脊液分流术。使用的数据集为该中心17年间的病例资料。结果显示患者生存期从1至22个月不等,平均为10.9个月。